EAS Consulting Group, a company focused on regulatory compliance for FDA- and USDA-regulated industries, is pleased to welcome Rob Williams to the EAS team as Business Development Director.
Rob is an accomplished business development executive with over a decade of experience driving sales growth, strategic partnerships, and market expansion across the healthcare and life sciences industries. In his role with EAS Consulting Group, Rob will support client engagement and growth initiatives across all FDA-regulated commodity areas, helping organizations identify and implement the regulatory and compliance solutions best suited to their needs.
Prior to joining EAS, Rob held key leadership roles in the medical technology sector, including Regional Sales Manager for Neocis, a pioneer in robotic dental surgery, and Senior Portfolio Business Development Manager for Pacira BioSciences, where he led opioid-free pain management initiatives throughout the Mid-Atlantic region. His achievements at Pacira included multiple top national rankings, including #1 for total revenue in several quarters and recognition among the top 10% of the national sales force.
Earlier in his career, Rob served in business development roles with Merit Medical Systems, Lumenis, and Oxford Immunotec, where he consistently exceeded growth targets and formed strategic partnerships with leading healthcare institutions such as Johns Hopkins, INOVA Health System, and Walter Reed National Military Medical Center.
Rob is recognized for his strategic approach to client engagement, leadership in collaborative business development environments, and commitment to advancing innovative healthcare solutions. His work at EAS will further strengthen support for clients navigating evolving regulatory and quality compliance expectations.

